Thermo Fisher Scientific (TMO) lifts guidance after topping Q1 expectations

Go back to Thermo Fisher Scientific (TMO) lifts guidance after topping Q1 expectations

Thermo Fisher Scientific (TMO) PT Raised to $610 at Deutsche Bank

April 25, 2024 6:16 AM EDT

Deutsche Bank analyst Justin Bowers raised the price target on Thermo Fisher Scientific (NYSE: TMO) to $610.00 (from $600.00) while maintaining a Buy rating.

The analyst comments "Messaging around bioprocessing was concise but positive, as order growth and book-to-bill continue to trend higher. We are... More

Thermo Fisher Scientific (TMO) Tops Q1 EPS by 40c, raises guidance

April 24, 2024 6:04 AM EDT

Thermo Fisher Scientific (NYSE: TMO) reported Q1 EPS of $5.11, $0.40 better than the analyst estimate of $4.71. Revenue for the quarter came in at $10.34 billion versus the consensus estimate of $10.16 billion.

GUIDANCE:

Thermo Fisher Scientific sees FY2024 EPS of $21.14-$22.02, versus the... More

Thermo Fisher Scientific (TMO) PT Raised to $621 at Baird

April 22, 2024 6:25 AM EDT

Baird analyst Catherine Schulte raised the price target on Thermo Fisher Scientific (NYSE: TMO) to $621.00 (from $597.00) while maintaining a Outperform rating.... More